These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Generation of C-reactive protein and complement components in atherosclerotic plaques. Yasojima K; Schwab C; McGeer EG; McGeer PL Am J Pathol; 2001 Mar; 158(3):1039-51. PubMed ID: 11238052 [TBL] [Abstract][Full Text] [Related]
3. Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease. Yasojima K; McGeer EG; McGeer PL Brain Res; 1999 Jul; 833(2):297-301. PubMed ID: 10375708 [TBL] [Abstract][Full Text] [Related]
4. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology. Hendrickx DAE; van Eden CG; Schuurman KG; Hamann J; Huitinga I J Neuroimmunol; 2017 Aug; 309():12-22. PubMed ID: 28601280 [TBL] [Abstract][Full Text] [Related]
5. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease. Mohri I; Kadoyama K; Kanekiyo T; Sato Y; Kagitani-Shimono K; Saito Y; Suzuki K; Kudo T; Takeda M; Urade Y; Murayama S; Taniike M J Neuropathol Exp Neurol; 2007 Jun; 66(6):469-80. PubMed ID: 17549007 [TBL] [Abstract][Full Text] [Related]
6. Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease. An L; Sato H; Konishi Y; Walker DG; Beach TG; Rogers J; Tooyama I Neurosci Lett; 2009 Mar; 452(3):277-80. PubMed ID: 19348738 [TBL] [Abstract][Full Text] [Related]
7. Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus. McLarnon JG; Ryu JK; Walker DG; Choi HB J Neuropathol Exp Neurol; 2006 Nov; 65(11):1090-7. PubMed ID: 17086106 [TBL] [Abstract][Full Text] [Related]
8. Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation. Walker DG; Dalsing-Hernandez JE; Campbell NA; Lue LF Exp Neurol; 2009 Jan; 215(1):5-19. PubMed ID: 18938162 [TBL] [Abstract][Full Text] [Related]
9. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Shen Y; Li R; McGeer EG; McGeer PL Brain Res; 1997 Sep; 769(2):391-5. PubMed ID: 9374212 [TBL] [Abstract][Full Text] [Related]
10. Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue. Overmyer M; Helisalmi S; Soininen H; Laakso M; Riekkinen P; Alafuzoff I Acta Neuropathol; 1999 Apr; 97(4):383-92. PubMed ID: 10208278 [TBL] [Abstract][Full Text] [Related]
11. Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's disease: morphometric study and review of the literature. Wojtera M; Sobów T; Kłoszewska I; Liberski PP; Brown DR; Sikorska B Folia Neuropathol; 2012; 50(1):74-84. PubMed ID: 22505366 [TBL] [Abstract][Full Text] [Related]
12. The role of inflammation in Alzheimer's disease. Tuppo EE; Arias HR Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976 [TBL] [Abstract][Full Text] [Related]
13. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers. Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448 [TBL] [Abstract][Full Text] [Related]
14. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease. Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049 [TBL] [Abstract][Full Text] [Related]
15. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease. Cai Z; Hussain MD; Yan LJ Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978 [TBL] [Abstract][Full Text] [Related]
16. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice. Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771 [TBL] [Abstract][Full Text] [Related]
17. The importance of inflammatory mechanisms in Alzheimer disease. McGeer EG; McGeer PL Exp Gerontol; 1998 Aug; 33(5):371-8. PubMed ID: 9762518 [TBL] [Abstract][Full Text] [Related]